These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3500430)

  • 41. [Therapeutic activity and pharmacokinetic behavior of miokamycin in the respiratory system].
    Fioretti M; Bandera M; Rimoldi R
    G Ital Chemioter; 1984; 31(1-2):145-8. PubMed ID: 6332040
    [No Abstract]   [Full Text] [Related]  

  • 42. [Multicenter study of cefoperazone in Austria].
    Forenbacher HH
    Wien Med Wochenschr; 1985 Mar; 135(5):123-6. PubMed ID: 3993050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of skin diseases of mixed aetiology in outpatients.
    Pagliano F
    Int J Tissue React; 1986; 8(2):149-52. PubMed ID: 3700004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Suppurative diseases of the skin and subcutaneous tissue in patients with diabetes mellitus].
    Marfin BI; Zeĭtlënok IuM; Shurupova FK
    Vestn Khir Im I I Grek; 1983 Apr; 130(4):60-2. PubMed ID: 6868292
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative study of TMS-19-Q and midecamycin for respiratory tract infection by double-blind method].
    Kobayashi H; Nihei T; Takeda H; Kohno K; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Kikuchi K; Yamamoto A
    Kansenshogaku Zasshi; 1985 Feb; 59(2):201-26. PubMed ID: 3925037
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of two dosage schedules of cephalexin in dermatologic infections.
    DiMattia AF; Sexton MJ; Smialowicz CR; Knapp WH
    J Fam Pract; 1981 Apr; 12(4):649-52. PubMed ID: 7205167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter clinical study of cefoperazone.
    Alix M; Arreza V; Brillantes S; Estrellado R; Gempesaw C; Monteron R; Pascasio F; Pena A; Claudio-Saniel M
    Clin Ther; 1984; 6(3):344-53. PubMed ID: 6722861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of cefuroxime in infective pluriorgan pathology. Observations on 60 cases].
    Failla S; Longo D; Fichera M
    Clin Ter; 1984 Nov; 111(3):227-42. PubMed ID: 6240364
    [No Abstract]   [Full Text] [Related]  

  • 49. [Josamycin in the treatment of bacterial broncho-pulmonary complications in polychemotherapy for advanced bronchogenic carcinoma].
    Salvati F; Antilli A; Lalli A; Signora M; Mecarocci D; Diana F; Orazi D
    G Ital Chemioter; 1985; 32(2):485-8. PubMed ID: 3833591
    [No Abstract]   [Full Text] [Related]  

  • 50. [Papain phonophoresis in the treatment of suppurative wounds and inflammatory processes].
    Matinian LA; Nagapetian KhO; Amirian SS; Mkrtchian SR; Mirzoian VS; Voskanian RM
    Khirurgiia (Mosk); 1990 Sep; (9):74-6. PubMed ID: 2273855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of Nafcillin natrium Polfa in selected skin diseases].
    Michalowski R; Miturska M; Toruń B; Urban J; Kucharska D
    Pol Tyg Lek; 1975 Nov; 30(47):1967-9. PubMed ID: 1197076
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical studies on TMS-19-Q.O tablets, the preparation of a new macrolide antibiotic, in the field of oral surgery].
    Sasaki J; Yamada Y; Takai H; Ohmura H; Abe H; Shiki K; Narita Y; Michi K; Ohno K; Kawanishi I
    Jpn J Antibiot; 1985 Mar; 38(3):615-33. PubMed ID: 3897602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Josamycin in oral infections].
    Donazzan M; Vigneul J
    Chir Dent Fr; 1988 Apr; 58(423):51-2. PubMed ID: 3234045
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical use and evaluation of 9,3"-di-0-acetyl midecamycin (MOM) in oral surgery].
    Satoh T; Sugiura Y; Fujiwara H; Suzuki M; Takahashi K; Saigusa F; Nishida K; Hisano Y
    Shigaku; 1982 Jun; 70(1):126-36. PubMed ID: 6985345
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method].
    Nohara N; Akagi O; Kanzaki H; Kanamoto A; Ohara A; Ohkawara A; Fukaya T; Kobayashi H; Yasuda H; Tagami H
    Kansenshogaku Zasshi; 1989 Mar; 63(3):203-27. PubMed ID: 2504834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New dosages of flucloxacillin makes therapy of skin and soft tissue infections simpler].
    Hedström SA; Svärd R
    Lakartidningen; 1992 Aug; 89(34):2669-70. PubMed ID: 1405850
    [No Abstract]   [Full Text] [Related]  

  • 57. Expression of antimicrobial peptides in cutaneous infections after skin surgery.
    Kesting MR; Stoeckelhuber M; Hölzle F; Mücke T; Neumann K; Woermann K; Jacobsen F; Steinstraesser L; Wolff KD; Loeffelbein DJ; Rohleder NH
    Br J Dermatol; 2010 Jul; 163(1):121-7. PubMed ID: 20346023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical evaluation of the TMS-19-Q.GC tablet in odontogenic infections. A comparative double-blind study with josamycin].
    Sasaki J; Yamada Y; Morihana K; Kaneko A; Takai H; Ohmura H; Abe H; Ikeshima K; Sesimo Y; Mishina M
    Jpn J Antibiot; 1985 May; 38(5):1389-419. PubMed ID: 3900458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical application of rokitamycin in pediatrics].
    Yanagawa Y; Fujita M; Hayakawa H
    Jpn J Antibiot; 1988 Jul; 41(7):871-4. PubMed ID: 3172460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of bacterial and mycotic skin infections in intertriginous spaces].
    Marghescu S
    Ther Ggw; 1975 Mar; 114(3):427-9, 432-4. PubMed ID: 1121676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.